Two in­vestors team up for Cor­den­Phar­ma buy­out fol­low­ing mR­NA vac­cine suc­cess

In March, Cor­den­Phar­ma was list­ed among the phar­ma gi­ants picked by the Ger­man gov­ern­ment as re­cip­i­ents of more than $3 bil­lion to en­sure that the coun­try had enough pro­duc­tion ca­pac­i­ty to make Covid-19 vac­cines for fu­ture out­breaks. In­vestors at As­torg and ICIG seemed to have liked what they saw and an­nounced Mon­day that the pri­vate eq­ui­ty firms have teamed up to ac­quire the CD­MO.

With the ac­qui­si­tion, As­torg and ICIG will get a rapid­ly grow­ing com­pa­ny thanks to its in­volve­ment in the mR­NA vac­cine game. Cor­den has al­so po­si­tioned it­self as a key play­er in the world of pep­tides and high-po­ten­cy com­pounds for on­col­o­gy. It picked up Vi­for Phar­ma’s drug man­u­fac­tur­ing wing in De­cem­ber 2021, land­ing op­er­a­tions in Fri­bourg and Et­tin­gen, Switzer­land, and Lis­bon, Por­tu­gal.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER